To view this email as a web page, click here.

ASCO: Can Changes in Diet Reduce Deaths From Breast Cancer?

Researchers looked at whether eating a low-fat diet helped improve survival in breast cancer, in a study presented ahead of the ASCO Annual Meeting.

ASCO: Promising Start to Pediatric MATCH Trial

Approximately 25% of patients with tumor samples submitted to the Pediatric MATCH program have been matched to an investigational therapy at an interim analysis reported ahead of the ASCO Annual Meeting.

IN CASE YOU MISSED IT

Final LATITUDE Results Confirm Previous Findings for High-Risk Prostate Cancer

Final results of LATITUDE confirm the benefit of abiraterone acetate plus prednisone along with ADT in high-risk metastatic castration-sensitive prostate cancer.

One FDA-Approved test analyzes 324 cancer-related genes

FoundationOne^®CDx analyzes all recommend genomic biomarkers for solid tumors, including companion diagnostic indications with direct paths to therapy. This one test can help guide therapy selection and clinical trial options for more patients.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.